1. Home
  2. BEN vs HOLX Comparison

BEN vs HOLX Comparison

Compare BEN & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Resources Inc.

BEN

Franklin Resources Inc.

HOLD

Current Price

$23.40

Market Cap

12.1B

Sector

Finance

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$74.98

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEN
HOLX
Founded
1947
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Electronics
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
16.6B
IPO Year
N/A
1990

Fundamental Metrics

Financial Performance
Metric
BEN
HOLX
Price
$23.40
$74.98
Analyst Decision
Hold
Hold
Analyst Count
11
15
Target Price
$23.05
$79.64
AVG Volume (30 Days)
4.3M
3.0M
Earning Date
11-07-2025
11-03-2025
Dividend Yield
5.47%
N/A
EPS Growth
7.28
N/A
EPS
0.91
2.49
Revenue
$8,770,700,000.00
$4,100,500,000.00
Revenue This Year
N/A
$6.69
Revenue Next Year
$5.60
$5.74
P/E Ratio
$25.71
$30.11
Revenue Growth
3.45
1.74
52 Week Low
$16.25
$51.90
52 Week High
$26.08
$80.31

Technical Indicators

Market Signals
Indicator
BEN
HOLX
Relative Strength Index (RSI) 60.98 67.93
Support Level $22.34 $74.55
Resistance Level $23.54 $75.12
Average True Range (ATR) 0.46 0.28
MACD 0.19 -0.14
Stochastic Oscillator 94.44 78.92

Price Performance

Historical Comparison
BEN
HOLX

About BEN Franklin Resources Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: